Blood test triggers early drug attack to stop breast Cancer's return
NCT ID NCT07292207
Summary
This study is testing if a drug called abemaciclib can prevent breast cancer from returning in people who have already had surgery and standard treatment. Researchers will use a special blood test to detect tiny traces of cancer early, and if found, participants will take the drug to try to stop the cancer from growing. The goal is to see if this early intervention approach helps keep people cancer-free longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nagoya City University
Nagoya, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.